Percutaneous Cardiopulmonary Support in Refractory No-Reflow with Cardiogenic Shock after Coronary Stenting in Acute Myocardial Infarction.
10.3349/ymj.2010.51.4.599
- Author:
Jung Woo SON
1
;
Jin Sun KIM
;
Jung Myung LEE
;
Sung Jin HONG
;
Min Kyu JUNG
;
Duk Hwan KIM
;
Jung Sun KIM
;
Donghoon CHOI
;
Yangsoo JANG
Author Information
1. Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea. kjs1218@yuhs.ac
- Publication Type:Case Reports
- Keywords:
No-reflow;
percutaneous cardiopulmonary support;
acute myocardial infarction
- From:Yonsei Medical Journal
2010;51(4):599-601
- CountryRepublic of Korea
- Language:English
-
Abstract:
Coronary no-reflow is defined as inadequate myocardial perfusion of a given coronary segment without angiographic evidence of mechanical vessel obstruction. No-reflow is visualized angiographically as a reduction in thrombolysis in myocardial infarction (TIMI) flow grade and is typically accompanied by chest pain, electrocardiographic changes with ST-segment shift and possible hemodynamic compromise. No-reflow during primary percutaneous coronary intervention (PCI) results in increasing mortality and morbidity. Therefore, treatment of noreflow is associated with improved clinical outcomes. Generally, the treatment of no-reflow is based on pharmacotherapy. In this case, despite maximal pharmacotherapy and intraaortic balloon pump (IABP), refractory no-reflow accompanied with cardiogenic shock was successfully treated with percutaneous cardiopulmonary support (PCPS).
